DHR vs UNH: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
UnitedHealth Group Incorporated · Healthcare
$375.21
+28.2% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
UNH |
| Current Price |
$221.12 |
$375.21 |
| Fair Value Estimate |
$286.52 |
$481.06 |
| Upside to Fair Value |
+29.6%
|
+28.2%
|
| Market Cap |
$155.4B |
$340.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
15.0x
|
| Price / Sales |
6.2x
|
0.8x
|
| Price / FCF |
28.5x
|
14.4x
|
| Revenue Growth YoY |
+5.5%
|
+0.4%
|
| Gross Margin |
58.5%
|
22.5%
|
| Operating Margin |
20.4%
|
4.8%
|
| Return on Equity |
7.7%
|
14.6%
|
| Dividend Yield |
0.65% |
2.41% |
| FCF Yield |
3.51%
|
6.95%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
UnitedHealth Group is the largest diversified healthcare enterprise in the United States, operating UnitedHealthcare insurance plans alongside Optum Health, Optum Insight, and Optum Rx, with 390,000 employees and a market capitalization of $340.74 billion. The business quality is high: a 14.6% return on equity, $26.07 in free cash flow per share, and a P/FCF of 14.39 demonstrate strong cash gener…
Accumulation Zones
| Metric |
DHR |
UNH |
| Zone Low |
$214.89 |
$360.80 |
| Zone High |
$243.54 |
$408.90 |
| In Buy Zone? |
Yes
|
Yes
|